Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 3565-3573, September 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juckett, D. A.
Right arrow Articles by Rosenberg, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juckett, D. A.
Right arrow Articles by Rosenberg, B.

Actions of cis-Diamminedichloroplatinum on Cell Surface Nucleic Acids in Cancer Cells as Determined by Cell Electrophoresis Techniques1

David A. Juckett2 and Barnett Rosenberg3

Department of Biophysics, Michigan State University, East Lansing, Michigan 48824

Whole-cell electrophoresis determinations, using a null technique to measure a cloud of cells, were made on a variety of tumor cell suspensions in order to examine the charged groups on the cell surfaces. We report here evidence, derived from these measurements, which indicates the presence of nucleic acids on the surfaces of the tumor cells. Cells of the ascitic and solid forms of the Sarcoma 180 mouse tumor, grown in ICR mice, showed a decrease of 10 to 20% in electrophoretic mobility when incubated with nucleases. One variant, S-180, exhibited sensitivity to RNase only; another variant was sensitive to both RNase and DNase, while different tumor lines were shown to be sensitive to DNase only. Treatment of tumorbearing animals with a therapeutic dose of cisplatin resulted in a loss of tumor cell mobility identical to that produced by the nuclease incubations of the control cells. Incubation of the cisplatin-treated tumor cells with nucleases produced no change in mobility. The isoelectric points of these cells were determined and are consistent with the loss of a group with a low pK value, such as the phosphates of RNA and DNA, in both cisplatin-treated cells and nuclease-incubated cells. Using the S-180 tumor sensitive to both RNase and DNase, the rates of the two enzymes were additive, but the mobility decreased to the same level regardless of whether the enzymes were used alone or together. This suggests that both enzymes act on the same site. RNase and DNase immobilized on agarose beads were capable of lowering the mobility of the cells upon incubation, confirming the surface location of these nucleic acid residues. S-180 tumor cells were also placed in a tissue culture medium at 37° for up to 22 hr and were treated in vitro with cisplatin and other metabolic inhibitors. Nucleic acid or protein synthesis inhibitors produced a loss of the cell surface nucleic acids. In another in vitro experiment, the nucleic acids were first removed by nucleases, and, when the cells were incubated at 37°, the nucleic acids reappeared. Disappearance with the inhibitors or reappearance after digestion exhibited a half-time of about 2 hr. Surface nucleic acids were detected by this electrophoresis technique on all of several types of tumor cells but not on any normal cells examined.

1 Research supported by Grant CA-11349 from the National Cancer Institute and by fellowships from Engelhard Industries; The International Nickel Co., Inc.; and Matthey Bishop, Inc.

2 Present address: Department of Biological Chemistry, St. Jude Children's Research Hospital, 332 N. Lauderdale, P. O. Box 318, Memphis, Tenn. 38101.

3 To whom requests for reprints should be addressed.

Received 8/24/81. Accepted 6/ 7/82.




This article has been cited by other articles:


Home page
GutHome page
J M Silva, R Rodriguez, J M Garcia, C Munoz, J Silva, G Dominguez, M Provencio, P Espana, and F Bonilla
Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells
Gut, April 1, 2002; 50(4): 530 - 534.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. S. Kopreski, F. A. Benko, L. W. Kwak, and C. D. Gocke
Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma
Clin. Cancer Res., August 1, 1999; 5(8): 1961 - 1965.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.